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Maternal Low-Level Lead Exposure and Fetal Growth
Motao Zhu,1 Edward F. Fitzgerald,2 Kitty H. Gelberg,3 Shao Lin,4 and Charlotte M. Druschel 4
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of Community Medicine, West Virginia University, Morgantown, West Virginia, USA; 2Department of Epidemiology and
Biostatistics, State University of New York at Albany, Rensselaer, New York, USA; 3Bureau of Occupational Health, New York State
Department of Health, Troy, New York, USA; 4Bureau of Environmental and Occupational Epidemiology, New York State Department of
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Background: Limited epidemiologic studies have examined the association between maternal
low-level lead exposure [blood lead (PbB) < 10 µg/dL] and fetal growth.
Objective: We examined whether maternal low-level lead exposure is associated with decreased
fetal growth.
Methods: We linked New York State Heavy Metals Registry records of women who had PbB
measurements with birth certificates to identify 43,288 mother–infant pairs in upstate New York
in a retrospective cohort study from 2003 through 2005. We used multiple linear regression with
fractional polynomials and logistic regression to relate birth weight, preterm delivery, and small for
gestational age to PbB levels, adjusting for potential confounders. We used a closed-test procedure
to identify the best fractional polynomials for PbB among 44 combinations.
Results: We found a statistically significant association between PbB (square root transformed) and
birth weight. Relative to 0 µg/dL, PbBs of 5 and 10 µg/dL were associated with an average of 61-g
and 87-g decrease in birth weight, respectively. The adjusted odds ratio for PbBs between 3.1 and
9.9 µg/dL (highest quartile) was 1.04 [95% confidence interval (CI), 0.89–1.22] for preterm delivery and 1.07 (95% CI, 0.93–1.23) for small for gestational age, relative to PbBs ≤ 1 µg/dL (lowest
quartile). No clear dose–response trends were evident when all of the quartiles were assessed.
Conclusions: Low-level PbB was associated with a small risk of decreased birth weight with a
supralinear dose–response relationship, but was not related to preterm birth or small for gestational
age. The results have important implications regarding maternal PbB.
K ey words : birth weight, blood lead, epidemiology, fetal growth, low-level lead exposure,
pregnancy, preterm birth, small for gestational age. Environ Health Perspect 118:1471–1475
(2010). doi:10.1289/ehp.0901561 [Online 21 June 2010]

With the banning of lead-based paint in 1977,
and the phasing out of lead-based gasoline
in the 1980s and its ban in 1996, the blood
lead (PbB) concentration among the general
U.S. population has been declining steadily
[Centers for Disease Control and Prevention
(CDC) 2005]. However, the general population exposure to low lead levels continues
because of the widespread use of lead and its
ubiquitous nature (CDC 2005). According to
the 2003–2004 National Health and Nutrition
Examination Survey (CDC 2005), the mean
PbB among women 18–49 years of age was
1.2 µg/dL, with a 95th percentile of 2.6 µg/dL.
PbBs < 10 µg/dL induce adverse effects
in humans, including elevated blood pressure, impaired nervous system development,
delayed sexual maturation, neurobehavioral
effects, depressed renal glomerular filtration
rate, and reduced heme synthesis [Agency
for Toxic Substances and Disease Registry
(ATSDR) 2007]. Furthermore, a clear threshold for these sensitive effects has not been
identified (ATSDR 2007). Maternal lead can
readily cross the placenta and enter fetal blood
circulation starting around week 12–14 of
pregnancy, making the fetus susceptible to
lead poisoning (Lin et al. 1998).
It is biologically plausible that lead can
induce low birth weight, preterm birth, and
small for gestational age. Lead can potentially impair normal fetal bone growth by
Environmental Health Perspectives •
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competing with calcium for deposition into
bone because lead and calcium have similar chemical characteristics (Potula 2005).
Experimental evidence provides support for
a potential effect of lead on preterm birth.
Lead impedes collagen synthesis and praline
hydroxylation in mouse, which may have deleterious effects on chorioamniotic membrane
structure and induce its premature rupture
(Torres-Sanchez et al. 1999). Rats exposed
to lead have reduced bone calcium content,
reduced trabecular bone volume, altered
growth plate morphology, and enhanced
activities of spontaneous uterine contraction
(Irgens 1998; Torres-Sanchez et al. 1999).
Limited epidemiologic studies have been
conducted to examine maternal low-level
lead exposure and fetal growth, especially
using PbBs (Irgens 1998; Magri et al. 2003;
Rothenberg et al. 2002; Sowers 2002; TorresSanchez et al. 1999). Some studies included
both low-level and high-level lead exposures,
restricting the conclusions regarding low-level
lead exposure alone (Torres-Sanchez et al.
1999). Other studies are based on convenience
samples such as prenatal clinic and Medicaid
participants, limiting their generalizability
(Sowers 2002).
Our study was designed to help address
some of these issues, using a large populationbased PbB registry in New York state. The
objectives were to examine whether maternal

118 | number 10 | October 2010

low-level PbB exposure (< 10 µg/dL) was
inversely associated with birth weight and
directly associated with the risk of preterm
birth, and small for gestational age.

Methods
Study population and data sources. The
study population comprised upstate New
York (New York State, excluding New York
City) mothers 15–49 years of age from 2003
through 2005 who had a PbB test before or
at the delivery date, and their singleton live
births. PbBs were obtained from the New
York State Heavy Metals Registry (HMR),
which has maintained a statewide database
since 1982 and receives reports on exposure
to heavy metals, including lead, mercury,
arsenic, and cadmium, from physicians and
laboratories (New York State Department
of Health Bureau of Occupational Health
2008a). In 1992 the reporting requirement
was changed from 25 µg/dL to include all
test reports regardless of level (New York
State Department of Health Bureau of
Occupational Health 2008a). Information
on birth outcomes and potential confounders
was acquired from the birth certificate files,
which are maintained by the New York State
Department of Health, Bureau of Biometrics.
Study design and data linkage. A retrospective cohort design was used. The existing
HMR records were linked with birth certificate files to form the study base. At first,
women with multiple PbB reports were
identified through deterministic matching
techniques and transposed into one record
containing information on all reporting dates
and PbBs. To minimize the issues of data
entry errors or missing values on identifiers,
10 deterministic identifiers were created using
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components from variables including the case
number, social security number, date of birth,
first name, last name, telephone number, ZIP
code, street address, sex, and street address
of the provider or physician ordering test.
During each step, 50 matches were randomly
selected and reviewed to ensure that the
matches were accurate, using all the potential
identifying variables: first name, last name,
middle name, date of birth, street address,
ZIP code, city, state, phone number, sex,
street address, name of the provider or physician ordering test, and reporting laboratory
identification number. A total of 215,426
women 15–49 years of age were identified
from 245,050 PbB tests that reported < 10
µg/dL from 2003 through 2005.
PbB data were then matched with birth
certificates to identify women who delivered
live infants. Twenty deterministic identifiers
were created using components from variables
including date of birth, social security number,
first name, middle name, last name, phone
number, residential street, and ZIP code of the
mother, and residential street and ZIP code
of the father. A total of 44,932 singleton live
births were identified with at least one PbB
test by delivery and the maximal lead level
< 10 µg/dL. We then excluded records with
implausible birth weight–gestational age combinations (Alexander et al. 1996) to reduce the
sample size to 44,873. Approximately 3.5% of
mothers had multiple singleton births during
the 3-year period, and we randomly selected
one birth to finalize 43,288 mother–infant
pairs. Approximately 3.0% of women received
multiple PbB tests, so we similarly selected one
test result at random.
This study was approved by the New York
State Department of Health and the State
University of New York at Albany institutional review boards.
Study variables. Exposure. PbB concentration was obtained from the HMR PbB reports.
The study level was restricted to < 10 µg/dL,
which accounted for 99.2% of reports. Atomic
spectrometry is the method for routine screening and diagnostic work (Parsons 1993). Its
accuracy is ± 1 µg/dL and the detection limit
is 1 µg/dL (Parsons 1993). Any errors in the
measurement of PbB would be expected to be
nondifferential according to low birth weight
and other fetal growth outcomes. Laboratories

are required to pass three of the quarterly proficiency tests every year by the New York State
Department of Health, Wadsworth Center
for Laboratories and Research, to ensure the
accuracy and comparability (Lin et al. 1998).
The coefficient of variation was approximately
7% among all laboratories in 2005 (New
York State Department of Health Wadsworth
Center 2006).
Outcomes. Birth outcomes were abstracted
from the birth certificate files. Only singleton live births were selected. Birth weight was
examined as a continuous variable. Preterm
birth was defined as the gestational age < 37
completed weeks from the date of the last menstrual period (March of Dimes Foundation
2007). Small for gestational age was defined
as the birth weight below the 10th percentile of birth weight for gestational age based
on the distribution of 1996–2000 national
birth weight by gestational week from week 25
through week 42 (Boulet et al. 2006). Binary
low birth weight (< 2,500 g) was not examined
in multiple variable analysis because continuous
birth weight provides more statistical power
to detect subtle effects. In addition, low birth
weight is a mix of preterm, growth-restricted,
and constitutionally small births; preterm birth
and small for gestational age were examined in
this study. Regarding the accuracy of outcomes
recorded in New York State birth certificates,
the dates of last menses reported in the birth
certificate exactly agreed with those recorded in
medical records for 87% (Roohan et al. 2003).
The agreement rate was increased to 93% when
the tolerance was 1 week (Roohan et al. 2003).
Confounders. In addition to the timing
of lead test in relation to the date of delivery,
various potential confounders were abstracted
from the BC files: maternal race (Caucasian,
African American, other); maternal ethnicity
(Hispanic or not); maternal age at the time of
delivery; maternal education (less than high
school graduate, high school graduate, some
college or college degree, graduate education);
participation in financial assistance programs
(e.g., Medicaid; Family Health Plus; Women,
Infants, and Children; other) (yes or no); selfreported maternal smoking during pregnancy
(yes or no); self-reported maternal alcohol
consumption during pregnancy (yes or no);
self-reported illicit drug use during pregnancy
(yes or no); trimester when prenatal care began

Table 1. Maternal and infant quantitative characteristics, upstate New York, 2003–2005.
Characteristic
PbB (μg/dL)
Days from lead test to date of
birth (day)
Maternal age (years)
Body mass index (kg/m2)
Gestational age (week)
Birth weight (g)

1472

n
Mean Minimum
43,288
2.1
0
43,288 203
0
43,288
27.6
40,797
26.4
43,288
38.8
43,288 3,331

15
12.5
20
205

10th
1
110

Selected percentiles
25th
50th
75th
1
2
3
170
204
223

90th
3
237

20
23
27
32
36
19.9
21.9
24.9
29.4
35.2
37
38
39
40
41
2,680 3,030 3,365 3,686 3,997

volume

Maximum
9.9
1,082
49
66.5
44
5,610

(first trimester, second trimester, third trimester, or no prenatal care); parity (zero, one, two
or more previous live births); sex of child; in
wedlock (yes or no); and prepregnancy body
mass index.
Statistical analysis. For continuous outcomes (birth weight in grams and gestational
age in days), we fitted multiple linear regression with fractional polynomials (Royston
et al. 1999). We explored one or two terms of
fractional polynomials in term of xp for PbB,
where the power p is from –2, –1, –0.5, 1,
2, 3, and natural logarithmic transformation.
The selection of final fractional polynomials
Table 2. Maternal and infant qualitative characteristics, upstate New York, 2003–2005 (total n = 43,288).
Characteristic
Race
Caucasian
African American
Other
Missing value
Ethnicity
Hispanic
Missing value
Education
Less than high school graduate
High school graduate
Some college or bachelor degree
Graduate study
Missing value
Smoking
Yes
Missing value
Alcohol drinking
Yes
Missing value
Drug abuse
Yes
Missing value
Financial assistance program
Yes
Missing value
Start of prenatal care visit
First trimester
Second trimester
Third trimester or no prenatal
care visit
Missing value
Parity
0
1
2 or more
Missing value
In wedlock
Yes
Missing value
Infant sex
Male
Low birth weight
Yes
Preterm birth
Yes
Small for gestational age
Yes
Missing value

n

Percentagea

29,434
7,113
6,689
52

68.0
16.5
15.5

8,447
492

19.7

10,054
11,675
16,857
4,337
365

23.4
27.2
39.3
10.1

8,834
149

20.5

493
196

1.1

1,216
973

2.9

25,803
114

59.8

29,187
8,811
2,056

72.9
22.0
5.1

3,234
17,376
13,715
11,823
374

40.4
32.0
27.6

20,378
261

47.4

22,154

51.2

2,744

6.3

3,519

8.1

4,092
112

9.5

aThe

calculation of percentage excluded missing values.
There were no missing values for infant sex, low birth
weight, and preterm birth.
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was based on a closed-test procedure, which
maintains the overall type 1 error (alpha level)
of 0.05 for tests among 44 different combinations (Royston et al. 1999). For each
outcome, a subset of biologically plausible
risk factors in addition to PbB was selected
to enter the model as potential confounders;
those that remained with a significance level
of 0.2 were retained (Dales and Urg 1978;
Mickey and Greenland 1989; Royston et al.
1999). Fractional polynomials were assessed
for continuous confounders including gestational age and maternal age for birth weight
outcome. Because the limit of detection for
the routine screening and diagnostic laboratory method is 1 µg/dL (Parsons 1993), we
conducted sensitivity analysis by a) comparing all records; b) excluding PbBs of 0 µg/dL;
c) excluding PbBs < 1 µg/dL.
Furthermore, the quartiles of PbBs
(≤ 1 µg/dL; > 1 µg/dL to 2 µg/dL; > 2 µg/dL
to 3 µg/dL; > 3 µg/dL to < 10 µg/dL) were
used for binary outcomes including preterm
birth and small for gestational age. Adjusted
odds ratios (aORs) of PbBs were estimated
from logistic regression with fractional poly
nomials (Allison 1999; Royston et al. 1999).
The quartiles of PbBs were forced into the
model. A closed-test procedure was used to
Table 3. Association between PbB concentration
and birth weight, upstate New York, 2003–2005.
Difference in birth weight
in grams (model based)a
Estimate
95% CI
Reference
–27.4
–17.1 to –37.8
–38.8
–24.1 to –53.4
–47.5
–29.6 to –65.4
–54.8
–34.2 to –75.5
–61.3
–38.2 to –84.4
–67.2
–41.8 to –92.5
–72.5
–45.2 to –99.9
–77.6
–48.3 to –106.8
–82.3
–51.2 to –113.3
–86.7
–54.0 to –119.4

PbB concentration
(μg/dL)
0
1
2
3
4
5
6
7
8
9
10
a The

model was a linear regression with fractional
polynomials after adjustment for timing of lead test,
gestational age, maternal age, race, Hispanic ethnicity, education, smoking, alcohol drinking, drug abuse,
in wedlock, participation in special financial assistant
program, parity, and infant sex. PbB concentration was
transformed using a square root. The coefficient was
–27.4 with an SE of 5.3.

Birth weight (g)

3,320
3,300
3,280
3,260
3,240

identify the 1 of 44 combinations of one
or two fractional polynomials with the best
model fit for continuous confounder: maternal age. The criteria for selecting and retaining
confounders in the logistic regression were
similar to those for linear regression. Analyses
were conducted using STATA version 11
(StataCorp, College Station, TX, USA).

Results
The average PbB concentration was 2.1 µg/dL,
and the median was 2 µg/dL (Table 1). The
average number of days from lead test to delivery was 203, and the 90th percentile was 237.
Most PbB tests were conducted between the
date of last menses and the date of delivery.
The average birth weight was 3,331 g, and gestational age was 38.8 weeks. Table 2 presents
the distribution of selected categorical maternal and infant characteristics. Approximately
68% of births were to white women, and
Hispanics accounted for 20%. The rates of
low birth weight, preterm birth, and small for
gestational age were 6.3%, 8.1%, and 9.5%,
respectively.
A model that assumed a linear relation
between the square root of PbB and birth
weight fit the data better than models with
all other combinations of fractional polynomial terms evaluated. Consequently, our final
model included only a single term for PbB
(raised to the 0.5 power), with an adjusted
coefficient of –27.4 [95% confidence interval
(CI), –37.7 to –17.1]. Estimated changes in
birth weight with a 1-µg/dL change in PbB
varied across the PbB distribution in the study
population, consistent with the supralinear
shape of the dose–response curve dictated by
the model, so that a 1-µg/dL change in PbB
from 0 µg/dL to 1 µg/dL was associated with a
27.4-g decrease in mean birth weight, whereas
a 1-µg/dL change in PbB from 9 µg/dL to
10 µg/dL was associated with a 4.4-g decrease
in mean birth weight (from a predicted mean
decrease relative to predicted mean birth
weight when PbB = 0 of 82.3 g to 86.7 g)
(Table 3). Therefore, the model predicts the
strongest estimated effects at the lowest levels
of exposure, without a lower threshold of PbB

below which there would be no predicted
effect on birth weight. Figure 1 displays this
dose–response relationship.
As for sensitivity analysis, the best-fit
fractional polynomials were PbB–1 + PbB–1
× logarithmic-transformed PbB, after excluding PbB of 0 µg/dL from analysis (data not
shown). Compared with PbB of 0.5 µg/dL,
PbB of 9.5 µg/dL was associated with a 51-g
decrease in birth weight. Compared with PbB
of 1 µg/dL, PbB of 10 µg/dL was associated
with a 32-g decrease in birth weight. When
PbBs < 1 µg/dL were excluded, untransformed
PbB fit the data the best, and the linear
regression coefficient was a 7.0-g decrease in
birth weight for a 1‑µg/dL increase in PbB.
Therefore, PbB of 10 µg/dL was associated
with a 63-g decrease in birth weight, relative
to PbB of 1 µg/dL. In contrast, the analysis
using all PbBs including zeros and < 1 µg/dL
suggested that PbB of 9.5 µg/dL was associated with an 84-g decrease in birth weight,
relative to PbB of 0.5 µg/dL, and that PbB of
10 µg/dL was associated with a 59-g decrease
in birth weight, relative to PbB of 1 µg/dL.
The analysis with all PbBs provided robust
estimated effects of lead on birth weight.
A model that assumed a linear relation
between untransformed PbB and gestational
age in days fit the data better than models
with all other combinations of fractional polynomial terms evaluated. Consequently, our
final model included only a single linear term
for PbB, with an adjusted coefficient of –0.09
(95% CI, –0.24 to 0.05) after adjustment for
timing of lead test, maternal age, race, smoking, alcohol consumption, participation in
special financial assistance program, parity,
and infant sex (data not shown).
Table 4 presents the association between
the quartile PbBs and dichotomous outcomes:
preterm birth and small for gestational age.
There were not clear dose–response trends
when all quartiles were assessed. The aORs
for PbBs between 3.1 and 9.9 µg/dL (highest
quartile) was 1.04 (95% CI, 0.89–1.22) for
preterm birth and 1.07 (95% CI, 0.93–1.23)
for small for gestational age, relative to
≤ 1 µg/dL (lowest quartile).

Table 4. Association between maternal PbB level and preterm birth, and small for gestational age,
upstate New York, 2003–2005.
Preterm birth
Small for gestational age
Maternal PbB level
Cases (n)
aORa
95% CI
Cases (n)
aORb
95% CI
≤ 1.0
1,069
1.00
Reference
1,168
1.00
Reference
1.1–2.0
1,036
1.03
0.93–1.13
1,268
1.07
0.98–1.17
2.1–3.0
1,171
1.01
0.92–1.10
1,353
1.06
0.98–1.16
3.1–9.9
243
1.04
0.89–1.22
303
1.07
0.93–1.23
aaORs

3,220
0

2

4

6

8

10

PbB (µg/dL)

Figure 1. Model-based dose–response relationship.
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are estimated from logistic regression with fractional polynomials after adjustment for timing of lead test,
maternal age at delivery, race, Hispanic ethnicity, smoking, drug abuse, in wedlock, participation in special financial
assistance program, parity, and infant sex. The quartiles of PbB concentration were untransformed, and fractional
polynomials were used for maternal age. baORs are estimated from logistic regression with fractional polynomials after
adjustment for timing of lead test, maternal age at delivery, race, education, smoking, drug abuse, in wedlock, participation in special financial assistance program, parity, and infant sex. The quartiles of PbB concentration were untransformed and fractional polynomials were assessed for maternal age.
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Discussion
Overall, maternal PbBs < 10 µg/dL were associated with a small but statistically significant decrease in birth weight. The decrease in
birth weight for a 1-µg/dL increase in PbB
ranged from an estimated means value of 4 g
(from 9 to 10 µg/dL) to 27 g (from 0 to 1 µg/
dL). This is consistent with the estimate of
a 6.2-g decrease in birth weight per 1-µg/dL
increase in PbB from a study of 272 mother–
infant pairs in Mexico (Gonzalez-Cossio et al.
1997); 3.0 g in a study of 4,354 pregnancies in Boston (Bellinger et al. 1991); 0.8 g
from a study of 54 term neonates in Turkey
(Atabek et al. 2007); and 0.3 g in a study of
55 newborns in Brazil (Zentner et al. 2006),
despite that fact that their mean lead levels
were higher than ours.
We found that a model of birth weight
as a function of square root–transformed
PbB provided the best fit to the data. This
model predicted estimated effects of lead
that were greater at the lower end of the PbB
distribution than at higher levels (supralinear dose–response relationship). A similar
supralinear relationship has been reported
for PbB < 10 µg/dL with IQ and Mental
Development Index (Canfield et al. 2003;
Lanphear et al. 2005; Tellez-Rojo et al.
2006). A pooled analysis of seven international prospective cohort studies found that
the decrease in full-scale IQ score per 1-µg/
dL increase in PbB estimated from the linear regression with untransformed PbB was
greater among children with a maximum PbB
< 7.5 µg/dL than in those with a maximum
PbB ≥ 7.5 µg/dL (Lanphear et al. 2005).
Further analysis suggested a linear relationship between the logarithmic-transformed
PbB and IQ (coefficient: 6.9) (Lanphear et al.
2005). An analysis of 294 children found a
logarithmic-transformed PbB was linearly
associated with Mental Development Index
(Tellez-Rojo et al. 2006). The estimated effect
of lead estimated from the linear regression
with untransformed PbB was larger at < 5
µg/dL than between 5 and 10 µg/dL (TellezRojo et al. 2006). Researchers have used
quadratic term (Canfield et al. 2003) and
logarithmic transformations (Lanphear et al.
2005; Tellez-Rojo et al. 2006) to describe
the supralinear relationship between lead and
intellectual impairment. We found that the
square root transformation provided the best
fit for birth weight, compared with 43 other
fractional polynomials linear, reciprocal, logarithmic, square foot, quadratic, and cubic
terms. Further studies are needed to confirm
whether the supralinear relationship between
PbB and birth weight is best described with
a square root transformation. Consistent
with previous studies of intellectual development (Canfield et al. 2003; Lanphear et al.
2005; Tellez-Rojo et al. 2006), our analysis
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supports that there is no clear threshold for
the effects of lead on sensitive outcomes such
as birth weight.
Bellinger et al. reported that the mean gestational age was 0.3 week longer among those
with umbilical cord PbBs 5.0–9.9 µg/dL,
relative to PbBs < 5.0 µg/dL (Bellinger et al.
1991). In contrast, we found that a 1-µg/dL
increase in maternal PbB was associated with
a statistically nonsignificant 0.09-day decrease
in gestational age. Similarly, Jelliffe-Pawlowski
et al. reported that among women with PbB
≥ 10 µg/dL, a 1-µg/dL increase in lead level
was associated with an average 0.3-day decrease
in gestational age (Jelliffe-Pawlowski et al.
2006). In a case–control study of 620 pregnant women in Mexico City, compared with
umbilical cord PbBs < 5.1 µg/dL, the aOR
of preterm birth for lead level 5.1–9.0 µg/dL
was 2.72 (95% CI, 1.03–7.19) among primi
parous women, but 0.48 (95% CI, 0.21–1.08)
among multiparous women (Torres-Sanchez
et al. 1999).
Bellinger et al. found that lead levels
between 5 and 9.9 µg/dL were not statistically
related to increased risk in dichotomous preterm birth and small for gestational age, compared with lead levels < 5 µg/dL (Bellinger
et al. 1991). A cohort study by Sowers (2002)
of 705 pregnant women in Camden, New
Jersey, did not find any statistically significant
association with dichotomous preterm birth,
or small for gestational age. Consistent with
their study, our study did not find statistically
significant associations.
Jelliffe-Pawlowski et al. reported that
women with PbBs ≥ 10 µg/dL were approximately three times as likely to experience a
preterm delivery as women with lead levels
< 10 µg/dL (aOR = 3.2; 95% CI, 1.2–7.4) and
that their risk of having a small-for-gestationalage infant was more than four times that of
women with lead levels < 10 µg/dL (aOR =
4.2; 95% CI, 1.3–13.9) (Jelliffe-Pawlowski
et al. 2006). Chen et al. (2006), in a study of
1,611 mother–infant pairs in Taiwan, China,
suggested that maternal PbBs of ≥ 10 µg/dL
were related to a doubling risk in low birth
weight, preterm birth, and small for gestational age compared with maternal PbBs
< 10 µg/dL. Highly elevated maternal PbBs
would be expected to have adverse effects on
fetal growth.
This study has multiple strengths. For
example, we used PbBs to measure the
absorbed dose circulated in the blood through
various exposure routes and sources for pregnant women, which is more accurate than
occupation history and other proxy exposure
measures. By restricting the lead concentrations to < 10 µg/dL, the associations between
maternal lead level and fetal growth found
in this study were not influenced by lead
concentrations > 10 µg/dL, unlike previous
volume

studies that included lead concentrations
below and > 10 µg/dL. Because this study was
based on a statewide registry and the study
lead concentration was close to the lead distribution among the general population, findings should be more generalizable than those
based on occupational settings or convenience
samples. Furthermore, this study had a large
sample size to detect subtle effects.
A possible limitation is selection bias. We
found that the mothers in this study were
younger and less likely to be Caucasian than
other mothers in upstate New York. The linkage rate of PbB reports with birth certificates
was higher for mothers 18–19 years of age,
African Americans, and with low-weight
births, consistent with the selective screening
for pregnant women at risk for adverse pregnancy outcome or lead exposure.
Dietary calcium and multiple vitamin use
during pregnancy could not be controlled,
as they were not collected on either the birth
certificates or the HMR. Low dietary calcium intake may increase the gastrointestinal absorption of lead (Bogden et al. 1995).
Calcium supplementation may reduce the
lead mobilization from bone during pregnancy and therefore reduce the potential lead
toxicity (Bellinger 2005; Han et al. 2000).
Furthermore, residual confounding may exist
because of the potential misclassification or
categorization of confounders. For example,
maternal smoking was recorded as “yes or no”
in birth certificates. Its sensitivity was 89%
and specificity was 99% using medical records
as a gold standard (Roohan et al. 2003). There
was no detailed information on the duration
and frequency of smoking.
The results of this study have important
implications regarding the recommended
action level for childhood PbB. Although
10 µg/dL is the current reference level set by
the CDC (ATSDR 2007), this study suggests
that maternal PbBs < 10 µg/dL may affect
fetal growth. This issue is of public health significance; in 2005, the HMR received about
84,000 reports on women in New York state
with PbBs < 10 μg/dL, and most of the reports
were regarding women of reproductive age.
Our study supports the continuation of lead
screening during pregnancy, especially among
women who are at risk because of current
high-dose exposure, which is recommended
by the New York State Department of Health
(New York State Department of Health
Bureau of Occupational Health 2008b).

Conclusion
Among pregnant women whose PbB was
< 10 µg/dL, PbB (square root transformed)
was inversely associated with birth weight.
Such findings suggest that the decrease in
birth weight per 1-µg/dL increase in PbB was
greater at lower concentrations than at higher
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concentrations without evidence of a lower
threshold of effect. These results are important, given the high prevalence of low-level
lead exposure among pregnant women and
the controversy regarding the recommended
action level for maternal PbB.
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